New Hope for Autoimmune Diseases

November sixth brings promising news in autoimmune disease research. Scientists are reprogramming overactive immune systems, showing early success for conditions like lupus. Studies also explore delaying disease onset, building on Type One diabetes successes. Despite diagnostic challenges due to vague symptoms and fluctuating severity, conditions like rheumatoid arthritis, Sjögrens disease, and lupus are at the forefront of this exciting research. The global market for autoimmune disease treatments is estimated at one hundred billion dollars annually, with new, targeted therapies emerging. The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.